Nutraceuticals as potential therapeutic agents for colon cancer: a review

被引:81
作者
Kuppusamy, Palaniselvam [1 ]
Yusoff, Mashitah M. [1 ]
Maniam, Gaanty Pragas [1 ]
Ichwan, Solachuddin Jauhari Arief [2 ]
Soundharrajan, Ilavenil [3 ]
Govindan, Natanamurugaraj [1 ]
机构
[1] Univ Malaysia Pahang, Fac Ind Sci & Technol, Mammalian Cell Technol Lab, Kuantan 26300, Pahang, Malaysia
[2] Int Islamic Univ Malaysia, Kulliyyah Dent, Kuantan 25200, Pahang, Malaysia
[3] Natl Inst Anim Sci, Dept Biochem, Suwon 441706, Gyeonggi, South Korea
关键词
Colon cancer; Nutraceuticals; Therapeutics; Marine organisms; Plant derivatives; CELL-CYCLE ARREST; COLORECTAL-CANCER; METABOLIC PATHWAYS; FATTY-ACIDS; APOPTOSIS; PREVENTION; PROLIFERATION; INHIBITION; EXPRESSION; MODULATION;
D O I
10.1016/j.apsb.2014.04.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Colon cancer is a world-wide health problem and the second -most dangerous type of cancer, affecting both men and women. The modern diet and lifestyles, with high meat consumption and excessive alcohol use, along with limited physical activity has led to an increasing mortality rate for colon cancer worldwide. As a result, there is a need to develop novel and environmentally benign drug therapies for colon cancer. Currently, nutraceuticals play an increasingly important role in the treatment of various chronic diseases such as colon cancer, diabetes and Alzheimer's disease. Nutraceuticals are derived from various natural sources such as medicinal plants, marine organisms, vegetables and fruits. Nutraceuticals have shown the potential to reduce the risk of colon cancer and slow its progression. These dietary substances target different molecular aspects of colon cancer development. Accordingly, this review briefly discusses the medicinal importance of nutraceuticals and their ability to reduce the risk of colorectal carcinogenesis. (C) 2014 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
引用
收藏
页码:173 / 181
页数:9
相关论文
共 84 条
[51]   Modulation of TNF-α-induced ICAM-1 expression, NO and H2O2 production by alginate, allicin and ascorbic acid in human endothelial cells [J].
Mo, SJ ;
Son, EW ;
Rhee, DK ;
Pyo, S .
ARCHIVES OF PHARMACAL RESEARCH, 2003, 26 (03) :244-251
[52]   Astaxanthin inhibits tumor invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-2 [J].
Nagendraprabhu, Ponnuraj ;
Sudhandiran, Ganapasam .
INVESTIGATIONAL NEW DRUGS, 2011, 29 (02) :207-224
[53]   Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer [J].
Nair, Hareesh B. ;
Sung, Bokyung ;
Yadav, Vivek R. ;
Kannappan, Ramaswamy ;
Chaturvedi, Madan M. ;
Aggarwal, Bharat B. .
BIOCHEMICAL PHARMACOLOGY, 2010, 80 (12) :1833-1843
[54]   Inhibition of human colon carcinoma development by lentinan from shiitake mushrooms (Lentinus edodes) [J].
Ng, ML ;
Yap, AT .
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2002, 8 (05) :581-589
[55]   Natural compounds for cancer treatment and prevention [J].
Nobili, Stefania ;
Lippi, Donatella ;
Witort, Ewa ;
Donnini, Martino ;
Bausi, Letizia ;
Mini, Enrico ;
Capaccioli, Sergio .
PHARMACOLOGICAL RESEARCH, 2009, 59 (06) :365-378
[56]   Xanthohumol induces apoptosis in cultured 40-16 human colon cancer cells by activation of the death receptor- and mitochondrial pathway [J].
Pan, L ;
Becker, H ;
Gerhäuser, C .
MOLECULAR NUTRITION & FOOD RESEARCH, 2005, 49 (09) :837-843
[57]  
Pandey M., 2010, ASIAN J PHARM CLIN R, V3, P11
[58]  
Pandey-Rai S., 2011, INT J PHARM BIO SCI, V2, P420
[59]  
Parodi PW, 2013, CURR PHARM DESIGN, V13, P813
[60]   β-Escin inhibits colonic aberrant crypt foci formation in rats and regulates the cell cycle growth by inducing p21waf1/cip1 in colon cancer cells [J].
Patiolla, Jagan M. R. ;
Raju, Jayadev ;
Swamy, Malisetty V. ;
Rao, Chinthalapally V. .
MOLECULAR CANCER THERAPEUTICS, 2006, 5 (06) :1459-1466